CSIMarket
 
Ambrx Biopharma Inc   (AMAM)
Other Ticker:  
 
 
Price: $28.0000 $0.02 0.071%
Day's High: $28 Week Perf: 0.21 %
Day's Low: $ 27.98 30 Day Perf: 0.79 %
Volume (M): 1,440 52 Wk High: $ 28.15
Volume (M$): $ 40,309 52 Wk Avg: $14.98
Open: $27.99 52 Wk Low: $6.55



 Market Capitalization (Millions $) 1,743
 Shares Outstanding (Millions) 62
 Employees -
 Revenues (TTM) (Millions $) 9
 Net Income (TTM) (Millions $) -134
 Cash Flow (TTM) (Millions $) -25
 Capital Exp. (TTM) (Millions $) 1

Ambrx Biopharma Inc
Ambrx Biopharma Inc is a biotechnology company focused on the development of innovative protein therapeutics. The company employs an advanced platform technology called Expanded Genetic Code, which allows for the incorporation of unnatural amino acids into proteins during their synthesis. This technology enables the creation of novel therapeutics with improved selectivity, potency, and pharmacokinetic properties.

Ambrx aims to address significant unmet medical needs by developing protein-based drugs for the treatment of various diseases, including cancer, metabolic disorders, and autoimmune diseases. The company collaborates with pharmaceutical partners to advance its pipeline of product candidates through preclinical and clinical development stages.

In addition to its proprietary pipeline, Ambrx also offers its Expanded Genetic Code technology to other pharmaceutical companies through collaborations and licensing agreements. This allows partners to develop their own customized protein therapeutics using the platform.

Overall, Ambrx Biopharma Inc is a biotech company utilizing a unique technology to develop innovative protein-based drugs that hold promise for improving patient care and addressing unmet medical needs.


   Company Address: 10975 North Torrey Pines Road La Jolla 92037 CA
   Company Phone Number: 875-2400   Stock Exchange / Ticker: NASDAQ AMAM
   AMAM is expected to report next financial results on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stock Market Announcement

Ambrx Biopharma Shareholders Approve Merger Agreement with Johnson & Johnson, Solidify Position in NASDAQ Biotechnology Index

Published Wed, Mar 6 2024 6:20 PM UTC


Date
Ambrx Biopharma, Inc., (NASDAQ: AMAM), made a significant announcement today as its shareholders unanimously approved the proposal to adopt the merger agreement entered into between the Company and Johnson & Johnson at its Special Meeting of Shareholders. Under the terms of this momentous transaction, shareholders of Ambrx will receive an impressive $28.00 per ...

Merger and Acquisition

Johnson & Johnson to Acquire Ambrx Biopharma, Revolutionizing Cancer Treatment with Next-Generation Antibody Drug Conjugates

Published Mon, Jan 8 2024 12:30 PM UTC

Johnson & Johnson's Acquisition of Ambrx Biopharma to Revolutionize Cancer Treatment
New Brunswick, N.J. - Johnson & Johnson, a leading pharmaceutical company, made a significant announcement today that it has inked a definitive agreement to acquire Ambrx Biopharma, Inc. (NASDAQ: AMAM) in a full-cash merger transaction. The deal amounts to a total equity value of about $...

Stock Market Announcement

Ambrx Biopharma, Inc. Joins NASDAQ Biotechnology Index, Signaling Growth Prospects for Shareholders

Published Thu, Dec 14 2023 1:49 PM UTC

Ambrx Biopharma, Inc. To Join NASDAQ Biotechnology Index, Signaling Potential Growth for Shareholders
SAN DIEGO, Dec. 14, 2023 - Ambrx Biopharma, Inc. (NASDAQ: AMAM), a leading biotechnology company, announced today its inclusion in the prestigious NASDAQ Biotechnology Index (NASDAQ: NBI), effective prior to the market open on Monday, December 18, 2023. This significant ...






 

Ambrx Biopharma Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com